A 10-year-old child with growth hormone deficiency is receiving growth hormone therapy. Which nursing intervention is most important during the initial phase of treatment?

Growth hormone (GH) therapy is a cornerstone of treatment for pediatric growth hormone deficiency (GHD), but it requires careful nursing management due to its significant metabolic effects. The most critical nursing intervention during the initial phase of treatment is vigilant monitoring of blood glucose levels and assessment for hyperglycemia or new-onset diabetes.

This intervention is paramount because of the well-established physiological antagonism between growth hormone and insulin. GH is a counter-regulatory hormone that promotes lipolysis and hepatic glucose production while simultaneously reducing insulin sensitivity in peripheral tissues like skeletal muscle and adipose tissue. When exogenous GH is introduced, especially at the initiation of therapy, this diabetogenic effect can be pronounced. The body's compensatory insulin secretion may be insufficient, leading to hyperglycemia. This is not merely a theoretical concern; the metabolic stress induced by GH can unmask underlying insulin resistance or directly impair glucose tolerance. The provided literature reinforces the clinical significance of monitoring metabolic parameters in the context of GH axis evaluation and treatment. For instance, studies evaluating GH deficiency and stimulation testing explicitly consider the influence of body mass index (BMI) on GH response, highlighting the intricate relationship between growth hormone, body composition, and metabolic health . Furthermore, the safety protocols for glucagon stimulation tests, which assess GH secretory capacity, systematically monitor for symptoms that can include metabolic disturbances, underscoring the clinical awareness of GH-related metabolic risks .

Let's analyze the other options to understand why they are incorrect or of lower priority:

• Option 1: Encourage the child to participate in competitive sports immediately. This is not a priority and could be harmful. While normal physical activity is encouraged for overall health, children with GHD often have delayed bone age and reduced muscle strength. Aggressive or competitive sports at the start of treatment, before significant growth and strength gains are achieved, could increase the risk of injury. The focus of initial therapy is on metabolic safety and establishing a routine, not immediate high-intensity physical performance.



• Option 2: Restrict the child's caloric intake to prevent rapid weight gain. This is incorrect. The goal of GH therapy is to promote linear growth, a highly anabolic process that requires adequate energy and protein. Restricting calories would be counterproductive and could compromise the growth response. While GH does promote lipolysis and can alter body composition over time, adequate nutrition is essential for "catch-up" growth. Monitoring for healthy weight gain is important, but caloric restriction is not a primary nursing intervention.



• Option 4: Administer the hormone injection only during daytime hours. This is incorrect. The standard practice for GH therapy is to mimic the body's natural pulsatile secretion, which occurs predominantly at night during sleep. Therefore, injections are typically given subcutaneously in the evening, at bedtime. This not only aligns with physiological rhythms but also helps establish a consistent daily routine, which is a key factor in treatment adherence. The development of user-friendly devices like auto-injectors is specifically aimed at overcoming challenges like needle anxiety to improve adherence to this daily or weekly regimen .

In summary, the initiation of GH therapy introduces a potent metabolic hormone that directly counteracts insulin. The resultant risk of hyperglycemia makes regular blood glucose monitoring the highest priority nursing intervention. This proactive surveillance allows for early detection and management of glucose intolerance, ensuring the safety of the child as they begin this long-term treatment. The complex interplay between growth hormone, body composition, and glucose metabolism is a central theme in endocrinology, relevant not only in primary GHD but also as a late effect of other pediatric treatments that can disrupt the GH/IGF-1 axis .